AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.4920
+0.0186 (3.93%)
At close: May 12, 2025, 4:00 PM
0.5000
+0.0080 (1.63%)
Pre-market: May 13, 2025, 5:10 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $5.18 million as of May 12, 2025. Its market cap has decreased by -96.81% in one year.
Market Cap
5.18M
Enterprise Value
18.12M
1-Year Change
-96.81%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $5.18M, a decrease of -91.86%. That is a compound annual growth rate of -45.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 4.99M | -76.90% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |